[18F]FDG PET/CT imaging of colorectal cancer: a pictorial review
- 1 March 2010
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 86 (1013) , 174-182
Abstract
Integrated positron emission tomography/CT (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a hybrid imaging modality which has recently become established in the staging, restaging and therapy response assessment of oncology patients. FDG PET/CT has several recognised applications in colorectal cancer (CRC) imaging including preoperative evaluation of apparently limited metastatic disease, detection of disease recurrence, clarification of equivocal lesions at initial staging, investigation of unexplained rising tumour markers, and incidental detection of occult primary colonic tumours. With a constantly advancing body of evidence and increasing availability, applications of PET/CT in CRC are likely to emerge in therapy response assessment, radiotherapy planning, use of novel tracers and ‘one-stop’ imaging techniques such as iodinated contrast-enhanced PET/CT. With the use of illustrative clinical examples, this article reviews the utility of FDG PET/CT in the management of CRC, discussing its role and limitations in the multimodality imaging of these patients.Keywords
This publication has 47 references indexed in Scilit:
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Systemic Treatment of Colorectal CancerGastroenterology, 2008
- Role of [18F]FDG-PET/CT after radiofrequency ablation of liver metastases: preliminary resultsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007
- Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 studyThe Lancet Oncology, 2007
- The role of 18F-fluoro-deoxy-glucose positron emission tomography (FDG-PET) in the management of patients with colorectal cancerEuropean Journal of Surgical Oncology, 2007
- Efficacy of PET/CT in the accurate evaluation of primary colorectal carcinomaEuropean Journal of Surgical Oncology, 2006
- Local staging of rectal cancer: the current role of MRIEuropean Radiology, 2006
- Positron emission tomography and colorectal carcinoma: an update1Journal of the American College of Surgeons, 2004
- The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancerDiseases of the Colon & Rectum, 1994